Overview
Join JLABS Singapore for an exclusive session with Flagship Pioneering, the venture creation company behind breakthrough platform companies including Moderna, Tessera Therapeutics, and Ring Therapeutics. This session will explore Flagship’s unique “invent and build” model, how it differs from traditional venture capital, and what it takes to translate bold scientific ideas into scalable companies. Through a presentation and panel discussion with leaders from Flagship Pioneering and Ring Therapeutics, gain insights into venture creation, platform company building, and opportunities for collaboration across Singapore and the wider Asia-Pacific life sciences ecosystem.
Advance registration is required for all guests. This event is intended for members of the life sciences community. The organizer reserves the right to decline or cancel registrations from individuals outside the intended audience or whose participation does not align with the purpose of the event. Registrations are non-transferable, and walk-ins will not be permitted.
Note: Photography and videography will be captured during this event. Through your participation, you are granting Johnson & Johnson consent to utilize these images and videos for promotional purposes, which may include social media, website and publication. If you do not wish to be photographed, kindly inform the photographer at the event.
Schedule
Date: 28 Aug 2026, Friday
Time: 3:00 PM - 6:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Bridge+ Geneo, 1A Science Park Drive, Singapore , 119314
